Veru Inc. (VERU) Stock Price & Analysis
Veru Inc. (VERU) rose 0.00% to USD 2.25 as of July 25, 2026 at 02:23 UTC, according to Nexqual real-time market data.
VERU last closed at USD 2.25; the session ranged USD 2.24–2.32 on volume of 100,616 shares. Market capitalization is —, with a 52-week range of USD 2.05–7.33 (NCM). Source: Nexqual, July 25, 2026 at 02:23 UTC.
Key Statistics (as of July 25, 2026 at 02:23 UTC)
| Price | USD 2.25 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 2.25 |
| Open | USD 2.25 |
| Day Range | USD 2.24 – 2.32 |
| 52-Week Range | USD 2.05 – 7.33 |
| Volume | 100,616 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (VERU)
Nexqual's technical model rates VERU "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:23 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.27 (neutral) |
| vs SMA50 | Below (USD 2.67) |
| MACD | -0.16 (negative) |
From Veru Inc.'s Latest SEC 10-K Filing (filed 2025-12-17)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GLSI | Greenwich LifeSciences, Inc. | USD 12.98 | ▼ 2.19% |
| FLNA | Filana Therapeutics, Inc. | USD 0.89 | ▼ 7.2% |
| OCGN | Ocugen, Inc. | USD 1.21 | ▼ 6.2% |
| TTOO | T2 Biosystems, Inc. | USD 0 | ▼ 77.78% |
| GOVX | GeoVax Labs, Inc. | USD 0.73 | ▼ 21.9% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:23 UTC. This page is informational and not investment advice.